Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Miller · SciRah

Researcher profile · Semantic Scholar

V. Miller

Share profile

V. Miller — researcher profile on SciRah

h-index: 123
Works: 919
Citations: 87K

Most-cited papers

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
J. Sicklick, S. Kato, R. Okamura, M. Schwaederlé +15 more
2019Nature Medicine621 citations Open access
Semantic Scholar
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
J. Rodón, J. Soria, R. Berger, Wilson H Miller +21 more
2019Nature Medicine513 citations Open access
Semantic Scholar
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database
G. Singal, P. Miller, V. Agarwala, Gerald Li +24 more
2019Journal of the American Medical Association (JAMA)501 citations Open access
Semantic Scholar
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer
M. Negrao, F. Skoulidis, M. Montesion, K. Schulze +34 more
2021Journal for ImmunoTherapy of Cancer282 citations Open access
Semantic Scholar
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
Shun Lu, Xiao-Rong Dong, H. Jian, Jian-Hua Chen +55 more
2022Journal of Clinical Oncology263 citations Open access
Semantic Scholar
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity
J. Robichaux, Y. Elamin, R. Vijayan, M. Nilsson +27 more
2020Cancer Cell206 citations Open access
Semantic Scholar
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability–High Cases in 67,000 Patient Samples
S. Trabucco, Kyle Gowen, S. Maund, E. Sanford +12 more
2019Journal of Molecular Diagnostics202 citations Open access
Semantic Scholar
Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
E. Sokol, D. Pavlick, Hossein Khiabanian, G. Frampton +11 more
2020JCO Precision Oncology149 citations Open access
Semantic Scholar
The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy
T. Knepper, M. Montesion, J. Russell, E. Sokol +12 more
2019Clinical Cancer Research144 citations Open access
Semantic Scholar
Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors
J. Chung, N. Dewal, E. Sokol, P. Mathew +14 more
2019JCO Precision Oncology144 citations Open access
Semantic Scholar
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer
Ping-Ping Mao, O. Cohen, K. Kowalski, Justin G Kusiel +16 more
2019Clinical Cancer Research122 citations Open access
Semantic Scholar
Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
A. Necchi, R. Madison, S. Pal, J. Ross +8 more
2020European Urology Focus95 citations Open access
Semantic Scholar
On-target resistance to the mutant-selective EGFR inhibitor osimertinib can develop in an allele specific manner dependent on the original EGFR activating mutation
Benjamin P. Brown, Yun-Kai Zhang, D. Westover, Ying Yan +11 more
2019Clinical Cancer Research95 citations Open access
Semantic Scholar
Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment
D. Wheeler, N. Takebe, T. Hinoue, K. Hoadley +42 more
2020Cancer Cell88 citations Open access
Semantic Scholar
Detection of Known and Novel FGFR Fusions in Non–Small Cell Lung Cancer by Comprehensive Genomic Profiling
A. Qin, A. Johnson, J. Ross, V. Miller +3 more
2019Journal of Thoracic Oncology86 citations
Semantic Scholar
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy
J. Jacob, E. Ferry, L. Gay, J. Elvin +15 more
2019Journal of Urology85 citations
Semantic Scholar
On the design, conduct and lessons learned from Lung-MAP (SWOG S1400): A biomarker-driven master protocol to evaluate biomarker-driven therapies for previously-treated squamous lung cancer
M. Redman, V. Papadimitrakopoulou, K. Minichiello, F. Hirsch +22 more
2020The Lancet Oncology83 citations Open access
Semantic Scholar
Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
A. Necchi, R. Madison, D. Raggi, J. Jacob +19 more
2020European Urology58 citations
Semantic Scholar
Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNA
Saranya Akumalla, R. Madison, D. Lin, A. Schrock +10 more
2020Oncology57 citations
Semantic Scholar
Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms
R. Eskander, J. Elvin, L. Gay, J. Ross +2 more
2020JCO Precision Oncology44 citations Open access
Semantic Scholar
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.
A. Necchi, G. Bratslavsky, R. Corona, J. Chung +15 more
2020European Urology Focus41 citations
Semantic Scholar
Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors.
A. Necchi, G. Bratslavsky, Rubin Pinkhasov, O. Shapiro +16 more
2019European Urology Focus40 citations Open access
Semantic Scholar
Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy.
Gerald Li, D. Pavlick, J. Chung, T. Bauer +19 more
2019Journal of Gastrointestinal Oncology34 citations Open access
Semantic Scholar
The Exceptional Responders Initiative: Feasibility of A National Cancer Institute Pilot Study.
B. Conley, L. Staudt, N. Takebe, D. Wheeler +35 more
2020Journal of the National Cancer Institute30 citations Open access
Semantic Scholar
FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape
S. Klempner, R. Madison, V. Pujara, J. Ross +9 more
2019The Oncologist30 citations Open access
Semantic Scholar
Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
K. Murugesan, Radwa Sharaf, M. Montesion, J. Moore +11 more
2021JCO Precision Oncology29 citations Open access
Semantic Scholar
Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness
A. Goodman, S. Kato, Ranajoy Chattopadhyay, R. Okamura +6 more
2019Cancer immunology research28 citations Open access
Semantic Scholar
Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling.
R. Madison, A. Schrock, E. Castellanos, J. Gregg +7 more
2020Lung Cancer27 citations Open access
Semantic Scholar
The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
U. Disel, R. Madison, K. Abhishek, J. Chung +30 more
2019The Oncologist27 citations Open access
Semantic Scholar
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
A. Tsimberidou, D. Hong, S. Fu, D. Karp +17 more
2021npj Precision Oncology25 citations Open access
Semantic Scholar
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions
R. Madison, Sumati V. Gupta, Y. Elamin, D. Lin +10 more
2020BJU International24 citations
Semantic Scholar
Correction: RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
S. Loi, S. Dushyanthen, P. Beavis, R. Salgado +21 more
2019Clinical Cancer Research23 citations Open access
Semantic Scholar
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas
S. Corso, F. Pietrantonio, M. Apicella, C. Migliore +38 more
2021Clinical Cancer Research18 citations Open access
Semantic Scholar
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma.
G. Bratslavsky, Stephanie Gleicher, J. Jacob, T. Sanford +14 more
2021Urologic oncology17 citations
Semantic Scholar
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
J. Riess, Shaila Rahman, W. Kian, C. Edgerly +19 more
2021Translational Oncology17 citations Open access
Semantic Scholar
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response
A. Valiakhmetova, S. Gorelyshev, A. Konovalov, Y. Trunin +17 more
2019The Oncologist16 citations Open access
Semantic Scholar
Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens
M. Hay, E. Severson, V. Miller, D. Liebner +3 more
2020JCO Precision Oncology11 citations Open access
Semantic Scholar
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
H. Vo, S. Fu, D. Hong, D. Karp +19 more
2022npj Precision Oncology9 citations Open access
Semantic Scholar
Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma.
L. Boussemart, A. Johnson, A. Schrock, S. Pal +11 more
2019Journal of American Academy of Dermatology9 citations Open access
Semantic Scholar
Characterization of 648 non-small cell lung cancer (NSCLC) cases with 28 unique HER2 exon 20 insertions.
S. Ou, R. Madison, J. Robichaux, J. Ross +4 more
2019Journal of Clinical Oncology9 citations
Semantic Scholar
Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
Erik A. Williams, N. Shah, N. Danziger, M. Montesion +6 more
2020Journal of American Academy of Dermatology8 citations Open access
Semantic Scholar
Hybrid Capture-Based Genomic Profiling Identifies BRAF V600 and Non-V600 Alterations in Melanoma Samples Negative by Prior Testing.
L. Boussemart, Annie W Nelson, M. Wong, J. Ross +7 more
2019The Oncologist8 citations Open access
Semantic Scholar
MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation.
L. Chu, Debra Franck, Christine A. Parachoniak, Jeffrey P. Gregg +9 more
2019The Oncologist8 citations Open access
Semantic Scholar
Atypical RAS Mutations in Metastatic Colorectal Cancer.
F. Pietrantonio, R. Yaeger, A. Schrock, G. Randon +21 more
2019JCO Precision Oncology8 citations Open access
Semantic Scholar
Attrition of Patients on a Precision Oncology Trial: Analysis of the I‐PREDICT Experience
Sandy S Bohan, J. Sicklick, Shumei Kato, R. Okamura +4 more
2020The Oncologist7 citations Open access
Semantic Scholar
MSI-H testing via hybrid capture based NGS sequencing of liquid biopsy samples.
Kyle Gowen, T. Clark, J. Gregg, Mandy Z. Greene +10 more
2019Journal of Clinical Oncology6 citations
Semantic Scholar
Comprehensive genomic profiling (CGP) of upper-tract (UTUC) and bladder (BUC) urothelial carcinoma reveals opportunities for therapeutic and biomarker development.
A. Necchi, S. Pal, J. Ross, R. Madison +8 more
2019Journal of Clinical Oncology6 citations
Semantic Scholar
Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation
Jamie A. Kmak, N. Agarwal, Yuting He, A. Heilmann +5 more
2020Case Reports in Oncology5 citations Open access
Semantic Scholar
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors
A. Schrock, R. Madison, M. Rosenzweig, Justin M. Allen +12 more
2020Lung Cancer5 citations Open access
Semantic Scholar
Penile and uterine cervical squamous cell carcinomas: A comparative genomic profiling study.
J. Jacob, R. Pinkhasov, O. Shapiro, Nick W. Liu +15 more
2019Journal of Clinical Oncology5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Ross×32
Invite
J. Ross — researcher profile on SciRah
Siraj M. Ali×28
Invite
Siraj M. Ali — researcher profile on SciRah
A. Schrock×22
Invite
A. Schrock — researcher profile on SciRah
J. Chung×17
Invite
J. Chung — researcher profile on SciRah

×13

Invite

G. Frampton — researcher profile on SciRah

Invite

R. Madison — researcher profile on SciRah

Invite

A. Necchi — researcher profile on SciRah

B. Alexander×9

Invite

B. Alexander — researcher profile on SciRah

Invite

L. Gay — researcher profile on SciRah

Invite

J. Elvin — researcher profile on SciRah

S. Ramkissoon×8

Invite

S. Ramkissoon — researcher profile on SciRah

Invite

J. Gregg — researcher profile on SciRah